Computer-aided drug discovery

Author(s):  
W. Graham Richards

Synopsis:The role of computers in drug discovery depends on just how much is known about the target macromolecule. If atomic detail of the receptor is known, binding free energy differences between drug variants may be computed. Major effort is being expended in extending the area of applicability of such studies by predicting protein structure based on homologies with known protein crystal data. Where no target structure is available, computational methods can provide leads by defining transition state structures and then using the approach of molecular similarity to define stable mimics to act as blockers.

Author(s):  
Christina Schindler ◽  
Hannah Baumann ◽  
Andreas Blum ◽  
Dietrich Böse ◽  
Hans-Peter Buchstaller ◽  
...  

Here we present an evaluation of the binding affinity prediction accuracy of the free energy calculation method FEP+ on internal active drug discovery projects and on a large new public benchmark set.<br>


Author(s):  
Lorenzo Casbarra ◽  
Piero Procacci

AbstractWe systematically tested the Autodock4 docking program for absolute binding free energy predictions using the host-guest systems from the recent SAMPL6, SAMPL7 and SAMPL8 challenges. We found that Autodock4 behaves surprisingly well, outperforming in many instances expensive molecular dynamics or quantum chemistry techniques, with an extremely favorable benefit-cost ratio. Some interesting features of Autodock4 predictions are revealed, yielding valuable hints on the overall reliability of docking screening campaigns in drug discovery projects.


2021 ◽  
Author(s):  
Yuriy Khalak ◽  
Gary Tresdern ◽  
Matteo Aldeghi ◽  
Hannah Magdalena Baumann ◽  
David L. Mobley ◽  
...  

The recent advances in relative protein-ligand binding free energy calculations have shown the value of alchemical methods in drug discovery. Accurately assessing absolute binding free energies, although highly desired, remains...


2012 ◽  
Vol 9 (1) ◽  
pp. 46-53 ◽  
Author(s):  
Kathleen E. Rogers ◽  
Juan Manuel Ortiz-Sánchez ◽  
Riccardo Baron ◽  
Mikolai Fajer ◽  
César Augusto F. de Oliveira ◽  
...  

Author(s):  
Christina Schindler ◽  
Hannah Baumann ◽  
Andreas Blum ◽  
Dietrich Böse ◽  
Hans-Peter Buchstaller ◽  
...  

Here we present an evaluation of the binding affinity prediction accuracy of the free energy calculation method FEP+ on internal active drug discovery projects and on a large new public benchmark set.<br>


2020 ◽  
Vol 60 (11) ◽  
pp. 5457-5474 ◽  
Author(s):  
Christina E. M. Schindler ◽  
Hannah Baumann ◽  
Andreas Blum ◽  
Dietrich Böse ◽  
Hans-Peter Buchstaller ◽  
...  

2021 ◽  
Author(s):  
Marcus Wieder ◽  
Josh Fass ◽  
John D. Chodera

The computation of tautomer ratios of druglike molecules is enormously important in computer-aided drug discovery, as over a quarter of all approved drugs can populate multiple tautomeric species in solution....


2020 ◽  
Author(s):  
Zhixiong Lin ◽  
Junjie Zou ◽  
Chunwang Peng ◽  
Shuai Liu ◽  
Zhipeng Li ◽  
...  

<p>Free energy perturbation (FEP) has become widely used in drug discovery programs for binding affinity prediction between candidate compounds and their biological targets. Simultaneously limitations of FEP applications also exist, including but not limited to, the high cost, long waiting time, limited scalability and application scenarios. To overcome these problems, we have developed a scalable cloud computing platform (XFEP) for both relative and absolute free energy predictions with refined simulation protocols. XFEP enables large-scale FEP calculations in a more efficient, scalable and affordable way, e.g. the evaluation of 5,000 compounds can be performed in one week using 50-100 GPUs with a computing cost approximately corresponding to the cost for one new compound synthesis. Together with artificial intelligence (AI) techniques for goal-directed molecule generation and evaluation, new opportunities can be explored for FEP applications in the drug discovery stages of hit identification, hit-to-lead, and lead optimization with R-group substitutions, scaffold hopping, and completely different molecule evaluation. We anticipate scalable FEP applications will become widely used in more drug discovery projects to speed up the drug discovery process from hit identification to pre-clinical candidate compound nomination. </p>


Sign in / Sign up

Export Citation Format

Share Document